19 April 2023 - PHARMAC has welcomed Dr Kiri Prentice (Ngāi Tūhoe and Ngāti Awa) to the newly established role ...
11 April 2023 - PHARMAC has announced the funding of risdiplam (Evrysdi) for people with the rare genetic disorder spinal muscular ...
5 April 2023 - PHARMAC’s consultation on rule 8.1b of the Pharmaceutical Schedule has now closed. ...
4 April 2023 - PHARMAC are consulting on the role of molnupiravir in New Zealand’s portfolio of COVID-19 treatments. ...
1 April 2023 The April 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
23 March 2023 - PHARMAC has initiated a consultation today on widening funded access to rituximab (branded as Riximyo) for ...
20 March 2023 - The government drug buying agency PHARMAC made extensive use of Wellington firm Draper Cormack Group. ...
20 March 2023 - PHARMAC has today been “outed” for using a media-avoiding strategy, something many journalists have long suspected. ...
13 March 2023 - Hayley Steele has a hefty price tag on her life, one worth almost $100,000. ...
7 March 2023 - PHARMAC has announced the funding of two new medicines - pembrolizumab (Keytruda) and atezolizumab (Tecentriq) for people ...
7 March 2023 - Pharmac has today confirmed the funding of elexacaftor with tezacaftor and ivacaftor (Trikafta) for people with cystic ...
3 March 2023 - PHARMAC will hear from people affected by rare disorders in its upcoming Rare Disorders Advisory Committee meeting ...
3 March 2023 - Jen Rowlands, 43, faces certain death from terminal cancer without a specific drug that could radically improve ...
3 March 2023 - "There are 30 actions we committed to in the interim response – these are part of ...
1 March 2023 - The March 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...